Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (RBR-4bmwsdz) titled 'Study on the use of Ibogaine for the treatment of Cocaine and Crack Addiction' on Oct. 22.
Study Type: Intervention
Study Design:
a phase 2-3, randomized-controlled, double-blind, parallel, treatment
Primary Sponsor: Instituto Veracruz de Pesquisa e Tratamento da Dependencia Quimica Ltda.
Condition:
Mental and behavioral disorders due to cocaine use - dependence syndrome
Intervention:
This is a phase II/III randomized, multicenter, double-blind clinical trial. In Part 1, 16 participants will be randomized in a 1:1:1:1 ratio into four treatment groups: ibogaine 9 mg/kg, ibogaine 12 mg/kg, ibogaine 15 mg/kg, or pl...